AGF Investments LLC Reduces Stake in UnitedHealth Group Inc (NYSE:UNH)

AGF Investments LLC lowered its holdings in UnitedHealth Group Inc (NYSE:UNH) by 26.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 2,774 shares of the healthcare conglomerate’s stock after selling 997 shares during the quarter. AGF Investments LLC’s holdings in UnitedHealth Group were worth $692,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Ellis Investment Partners LLC lifted its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Ellis Investment Partners LLC now owns 568 shares of the healthcare conglomerate’s stock worth $134,000 after buying an additional 35 shares during the period. Moloney Securities Asset Management LLC lifted its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Moloney Securities Asset Management LLC now owns 10,133 shares of the healthcare conglomerate’s stock valued at $2,979,000 after purchasing an additional 38 shares during the period. Clear Harbor Asset Management LLC lifted its stake in shares of UnitedHealth Group by 0.6% in the 4th quarter. Clear Harbor Asset Management LLC now owns 6,613 shares of the healthcare conglomerate’s stock valued at $1,944,000 after purchasing an additional 40 shares during the period. Adviser Investments LLC lifted its stake in shares of UnitedHealth Group by 2.1% in the 4th quarter. Adviser Investments LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $570,000 after purchasing an additional 40 shares during the period. Finally, Bfsg LLC lifted its stake in shares of UnitedHealth Group by 2.0% in the 1st quarter. Bfsg LLC now owns 2,048 shares of the healthcare conglomerate’s stock valued at $511,000 after purchasing an additional 40 shares during the period. Institutional investors and hedge funds own 87.10% of the company’s stock.

A number of research analysts have recently commented on the company. Stephens raised their target price on UnitedHealth Group from $300.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, April 15th. Raymond James reduced their price objective on UnitedHealth Group from $340.00 to $325.00 in a research report on Thursday, April 16th. Barclays reaffirmed a “buy” rating and set a $322.00 price objective on shares of UnitedHealth Group in a research report on Sunday, March 29th. SunTrust Banks raised their price objective on UnitedHealth Group from $340.00 to $360.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Cowen raised their price objective on UnitedHealth Group from $320.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday, April 16th. Four research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $319.68.

Shares of UNH opened at $289.94 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.75 and a quick ratio of 0.75. UnitedHealth Group Inc has a one year low of $187.72 and a one year high of $306.71. The firm has a market capitalization of $272.10 billion, a P/E ratio of 19.00, a PEG ratio of 1.41 and a beta of 0.72. The business has a fifty day moving average of $277.58 and a 200 day moving average of $277.14.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, April 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.63 by $0.09. UnitedHealth Group had a return on equity of 24.86% and a net margin of 5.59%. The company had revenue of $64.40 billion during the quarter, compared to analyst estimates of $64.25 billion. During the same quarter in the previous year, the company posted $3.73 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Analysts expect that UnitedHealth Group Inc will post 16.24 EPS for the current fiscal year.

In related news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction on Friday, March 20th. The stock was sold at an average price of $228.39, for a total transaction of $2,283,900.00. Following the transaction, the director now directly owns 158,598 shares in the company, valued at $36,222,197.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $212.00, for a total value of $1,060,000.00. Following the transaction, the director now owns 158,598 shares in the company, valued at $33,622,776. The disclosure for this sale can be found here. Insiders sold 65,637 shares of company stock valued at $17,723,013 in the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Nikkei 225 Index

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.